PD-L1+, FAS+ and CD73+ tumor cells were found at higher frequencies within MSLN+ SKOV-3 cells compared with MSLN- SKOV-3 cells, regardless of treatment group M28z and MBBz (figure 2F). This evidence concerns the gene MSLN and neoplasm.